Company profile
Mondego Bio company profile
Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
Business identity
- Website
- https://www.mondegobio.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
Headquarters
- Headquarters
- Cantanhede, Coimbra, Portugal
- Country code
- PT
- Continent
- Europe